News

Health Canada approves clinical trial for ToeFX Light Therapy Device

clinical-trial-approved

ToeFX Inc., a Canadian medical device company developing a novel photodynamic therapy for onychomycosis, announced today that it has received Investigational Testing Approval (ITA) from Health Canada. Under the ITA, the company is authorized to begin clinical trials of the ToeFX Light Therapy device at the Hamilton Foot Clinic in Hamilton, Ontario. Trials are expected to begin in early 2020. The trial’s principal investigator is Dr. Alexander Rabinovich, MD, FRCSC, an orthopaedic surgeon and Assistant Clinical Professor (Adjunct) at McMaster University.

Read More

CTO Irit Van-Ham shortlisted for Women in IT Award

Irit Van Ham ToeFX CEO

The Women In IT Canada event celebrates talented high achievers in IT, bestowing significant awards for the industry, while paving the way for the future generation. ToeFX Inc. is proud to announce that our very own Dr. Irit Van-Ham has been shortlisted for the CTO of the Year category for 2019. The awards ceremony will take place on November 21, 2019. The Women in IT event is presented by Information Age and Bonhill Plc. Good luck Irit!

Read More

ToeFX receives $30,000 grant for lab studies

ToeFX technology research

ToeFX received a Voucher for Innovation and Productivity (VIP) grant from the Ontario Centres of Excellence.  These grants help companies develop, implement and commercialize technical innovations by supporting partnerships between Ontario’s industry and publicly funded post-secondary institutions. Working with researchers at McMaster University, ToeFX has successfully concluded ex vivo trials of its flagship product.  The ex vivo trials were conducted using ToeFX’s photodynamic therapy treatment, comprising a propriety formulation and custom light source.

Read More